Mikko Airavaara
Cited by
Cited by
Neurobiology of the incubation of drug craving
CL Pickens, M Airavaara, F Theberge, S Fanous, BT Hope, Y Shaham
Trends in neurosciences 34 (8), 411-420, 2011
Development and plasticity of meningeal lymphatic vessels
S Antila, S Karaman, H Nurmi, M Airavaara, MH Voutilainen, T Mathivet, ...
Journal of Experimental Medicine 214 (12), 3645-3667, 2017
Role of BDNF and GDNF in drug reward and relapse: a review
UE Ghitza, H Zhai, P Wu, M Airavaara, Y Shaham, L Lu
Neuroscience & Biobehavioral Reviews 35 (2), 157-171, 2010
Effects of neurotrophic factors in glial cells in the central nervous system: expression and properties in neurodegeneration and injury
S Pöyhönen, S Er, A Domanskyi, M Airavaara
Frontiers in physiology 10, 486, 2019
Mesencephalic astrocyte‐derived neurotrophic factor reduces ischemic brain injury and promotes behavioral recovery in rats
M Airavaara, H Shen, CC Kuo, J Peränen, M Saarma, B Hoffer, Y Wang
Journal of Comparative Neurology 515 (1), 116-124, 2009
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS
ST Lim, M Airavaara, BK Harvey
Pharmacological research 61 (1), 14-26, 2010
CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice
M Airavaara, BK Harvey, MH Voutilainen, H Shen, J Chou, P Lindholm, ...
Cell transplantation 21 (6), 1213-1223, 2012
Mesencephalic astrocyte-derived neurotrophic factor (MANF) secretion and cell surface binding are modulated by KDEL receptors
MJ Henderson, CT Richie, M Airavaara, Y Wang, BK Harvey
Journal of Biological Chemistry 288 (6), 4209-4225, 2013
Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke
BK Harvey, M Airavaara, J Hinzman, EM Wires, MJ Chiocco, DB Howard, ...
PloS one 6 (8), e22135, 2011
Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease
M Airavaara, O Pletnikova, ME Doyle, YE Zhang, JC Troncoso, QR Liu
Journal of Biological Chemistry 286 (52), 45093-45102, 2011
Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors
JE Anttila, KW Whitaker, ES Wires, BK Harvey, M Airavaara
Progress in Neuro-Psychopharmacology and Biological Psychiatry 79, 3-14, 2017
Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson’s disease
MH Voutilainen, U Arumäe, M Airavaara, M Saarma
FEBS letters 589 (24), 3739-3748, 2015
Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury
M Airavaara, MJ Chiocco, DB Howard, KL Zuchowski, J Peränen, C Liu, ...
Experimental neurology 225 (1), 104-113, 2010
Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases …
J Mijatovic, M Airavaara, A Planken, P Auvinen, A Raasmaja, ...
Journal of Neuroscience 27 (18), 4799-4809, 2007
MANF promotes differentiation and migration of neural progenitor cells with potential neural regenerative effects in stroke
KY Tseng, JE Anttila, K Khodosevich, RK Tuominen, M Lindahl, ...
Molecular therapy 26 (1), 238-255, 2018
Prospects of neurotrophic factors for Parkinson's disease: comparison of protein and gene therapy
A Domanskyi, M Saarma, M Airavaara
Human gene therapy 26 (8), 550-559, 2015
Neuron-specific genome modification in the adult rat brain using CRISPR-Cas9 transgenic rats
S Bäck, J Necarsulmer, LR Whitaker, LM Coke, P Koivula, EJ Heathward, ...
Neuron 102 (1), 105-119. e8, 2019
Update of neurotrophic factors in neurobiology of addiction and future directions
M Koskela, S Bäck, V Võikar, CT Richie, A Domanskyi, BK Harvey, ...
Neurobiology of disease 97, 189-200, 2017
Poststroke delivery of MANF promotes functional recovery in rats
K Mätlik, JE Anttila, T Kuan-Yin, OP Smolander, E Pakarinen, L Lehtonen, ...
Science advances 4 (5), eaap8957, 2018
AAV vector-mediated gene delivery to substantia nigra dopamine neurons: implications for gene therapy and disease models
K Albert, MH Voutilainen, A Domanskyi, M Airavaara
Genes 8 (2), 63, 2017
The system can't perform the operation now. Try again later.
Articles 1–20